is semaglutide approved by fda Approves Oral as First GLP-1 Pill for Weight Loss US FDA accepts Novo Nordisk's

The weight loss achieved through semaglutide treatment can lead to a decrease in estrogen levels produced by adipose tissue, which in turn can help in rebalancing testosterone levels, enhancing sexual function, and improving semen parameters

Weight loss through diet and exercise alone can be challenging at such BMI levels

A 2022 study published in JAMA Network Open found that people taking antidepressants experienced somewhat reduced weight loss with GLP-1 medications compared to those not taking antidepressants

Retrieved from Swaminathan, S., Dehghan, M., Raj, J

Semaglutide is one of the GLP-1 receptor agonist therapies that certifeid providers prescribes at Cosmetic Injectables Center Medspa in Sherman Oaks for adult patients meeting clinical criteria for chronic weight management or related metabolic conditions